Leigh M Howard1, Kathryn M Edwards1, Yuwei Zhu2, Derek J Williams1, Wesley H Self3, Seema Jain4, Krow Ampofo5, Andrew T Pavia5, Sandra R Arnold6, Jonathan A McCullers6,7, Evan J Anderson8, Richard G Wunderink9, Carlos G Grijalva10. 1. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 2. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 3. Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 4. Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 5. University of Utah Health Sciences Center, Salt Lake City, Utah, USA. 6. University of Tennessee Health Sciences Center, Memphis, Tennessee, USA. 7. St Jude Children's Research Hospital, Memphis, Tennessee, USA. 8. Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. 9. Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 10. Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Abstract
BACKGROUND: Parainfluenza virus (PIV) is a leading cause of lower respiratory tract infections. Although there are several distinct PIV serotypes, few studies have compared the clinical characteristics and severity of infection among the individual PIV serotypes and between PIV and other pathogens in patients with community-acquired pneumonia. METHODS: We conducted active population-based surveillance for radiographically confirmed community-acquired pneumonia hospitalizations among children and adults in 8 US hospitals with systematic collection of clinical data and respiratory, blood, and serological specimens for pathogen detection. We compared clinical features of PIV-associated pneumonia among individual serotypes 1, 2, and 3 and among all PIV infections with other viral, atypical, and bacterial pneumonias. We also compared in-hospital disease severity among groups employing an ordinal scale (mild, moderate, severe) using multivariable proportional odds regression. RESULTS: PIV was more commonly detected in children (155/2354; 6.6%) than in adults (66/2297; 2.9%) (P < .001). Other pathogens were commonly co-detected among PIV cases (110/221; 50%). Clinical features of PIV-1, PIV-2, and PIV-3 infections were similar to one another in both children and adults with pneumonia. In multivariable analysis, children with PIV-associated pneumonia exhibited similar severity to children with other nonbacterial pneumonia, whereas children with bacterial pneumonia exhibited increased severity (odds ratio, 8.42; 95% confidence interval, 1.88-37.80). In adults, PIV-associated pneumonia exhibited similar severity to other pneumonia pathogens. CONCLUSIONS: Clinical features did not distinguish among infection with individual PIV serotypes in patients hospitalized with community-acquired pneumonia. However, in children, PIV pneumonia was less severe than bacterial pneumonia.
BACKGROUND: Parainfluenza virus (PIV) is a leading cause of lower respiratory tract infections. Although there are several distinct PIV serotypes, few studies have compared the clinical characteristics and severity of infection among the individual PIV serotypes and between PIV and other pathogens in patients with community-acquired pneumonia. METHODS: We conducted active population-based surveillance for radiographically confirmed community-acquired pneumonia hospitalizations among children and adults in 8 US hospitals with systematic collection of clinical data and respiratory, blood, and serological specimens for pathogen detection. We compared clinical features of PIV-associated pneumonia among individual serotypes 1, 2, and 3 and among all PIV infections with other viral, atypical, and bacterial pneumonias. We also compared in-hospital disease severity among groups employing an ordinal scale (mild, moderate, severe) using multivariable proportional odds regression. RESULTS: PIV was more commonly detected in children (155/2354; 6.6%) than in adults (66/2297; 2.9%) (P < .001). Other pathogens were commonly co-detected among PIV cases (110/221; 50%). Clinical features of PIV-1, PIV-2, and PIV-3 infections were similar to one another in both children and adults with pneumonia. In multivariable analysis, children with PIV-associated pneumonia exhibited similar severity to children with other nonbacterial pneumonia, whereas children with bacterial pneumonia exhibited increased severity (odds ratio, 8.42; 95% confidence interval, 1.88-37.80). In adults, PIV-associated pneumonia exhibited similar severity to other pneumonia pathogens. CONCLUSIONS: Clinical features did not distinguish among infection with individual PIV serotypes in patients hospitalized with community-acquired pneumonia. However, in children, PIV pneumonia was less severe than bacterial pneumonia.
Authors: Maria Angeles Marcos; Marta Camps; Tomás Pumarola; José Antonio Martinez; Esteban Martinez; Josep Mensa; Elisa Garcia; Georgina Peñarroja; Póvilas Dambrava; Inmaculada Casas; Maria Teresa Jiménez de Anta; Antoni Torres Journal: Antivir Ther Date: 2006
Authors: Anne J Blaschke; Caroline Heyrend; Carrie L Byington; Ignacio Obando; Isabel Vazquez-Barba; Elizabeth H Doby; E Kent Korgenski; Xiaoming Sheng; Mark A Poritz; Judy A Daly; Edward O Mason; Andrew T Pavia; Krow Ampofo Journal: Pediatr Infect Dis J Date: 2011-04 Impact factor: 2.129
Authors: A Marx; H E Gary; B J Marston; D D Erdman; R F Breiman; T J Török; J F Plouffe; T M File; L J Anderson Journal: Clin Infect Dis Date: 1999-07 Impact factor: 9.079
Authors: Alicia M Fry; Aaron T Curns; Kathryn Harbour; Lori Hutwagner; Robert C Holman; Larry J Anderson Journal: Clin Infect Dis Date: 2006-09-13 Impact factor: 9.079
Authors: Marie R Griffin; Frances J Walker; Marika K Iwane; Geoffrey A Weinberg; Mary Allen Staat; Dean D Erdman Journal: Pediatr Infect Dis J Date: 2004-11 Impact factor: 2.129
Authors: Geoffrey A Weinberg; Caroline B Hall; Marika K Iwane; Katherine A Poehling; Kathryn M Edwards; Marie R Griffin; Mary Allen Staat; Aaron T Curns; Dean D Erdman; Peter G Szilagyi Journal: J Pediatr Date: 2009-01-21 Impact factor: 4.406
Authors: Daniel R Feikin; Wei Fu; Daniel E Park; Qiyuan Shi; Melissa M Higdon; Henry C Baggett; W Abdullah Brooks; Maria Deloria Knoll; Laura L Hammitt; Stephen R C Howie; Karen L Kotloff; Orin S Levine; Shabir A Madhi; J Anthony G Scott; Donald M Thea; Peter V Adrian; Martin Antonio; Juliet O Awori; Vicky L Baillie; Andrea N DeLuca; Amanda J Driscoll; Bernard E Ebruke; Doli Goswami; Ruth A Karron; Mengying Li; Susan C Morpeth; John Mwaba; James Mwansa; Christine Prosperi; Pongpun Sawatwong; Samba O Sow; Milagritos D Tapia; Toni Whistler; Khalequ Zaman; Scott L Zeger; Katherine L O' Brien; David R Murdoch Journal: Clin Infect Dis Date: 2017-06-15 Impact factor: 9.079
Authors: Philip Maykowski; Marie Smithgall; Philip Zachariah; Matthew Oberhardt; Celibell Vargas; Carrie Reed; Ryan T Demmer; Melissa S Stockwell; Lisa Saiman Journal: Influenza Other Respir Viruses Date: 2018-08-29 Impact factor: 4.380
Authors: Cyril Le Nouën; Christine E Nelson; Xueqiao Liu; Hong-Su Park; Yumiko Matsuoka; Cindy Luongo; Celia Santos; Lijuan Yang; Richard Herbert; Ashley Castens; Ian N Moore; Temeri Wilder-Kofie; Rashida Moore; April Walker; Peng Zhang; Paolo Lusso; Reed F Johnson; Nicole L Garza; Laura E Via; Shirin Munir; Daniel Barber; Ursula J Buchholz Journal: bioRxiv Date: 2022-05-23